South Africa Gastrointestinal Therapeutics Market, 2025-2033
The gastrointestinal therapeutics market in South Africa is expected to reach a projected revenue of US$ 480.2 million by 2033. A compound annual growth rate of 3.3% is expected of South Africa gastrointestinal therapeutics market from 2026 to 2033.
South Africa gastrointestinal therapeutics market highlights
The South Africa gastrointestinal therapeutics market generated a revenue of USD 370.6 million in 2025 and is expected to reach USD 480.2 million by 2033.
The South Africa market is expected to grow at a CAGR of 3.3% from 2026 to 2033.
In terms of segment, branded was the largest revenue generating drug type in 2025.
Generics is the most lucrative drug type segment registering the fastest growth during the forecast period.
Gastrointestinal therapeutics market data book summary
Market revenue in 2025
USD 370.6 million
Market revenue in 2033
USD 480.2 million
Growth rate
3.3% (CAGR from 2026 to 2033)
Largest segment
Branded
Fastest growing segment
Generics
Historical data
2021 - 2024
Base year
2025
Forecast period
2026 - 2033
Quantitative units
Revenue in USD million
Market segmentation
Branded, Generics
Key market players worldwide
AbbVie Inc, AstraZeneca PLC, Bausch Health Companies Inc, Takeda Pharmaceutical Co Ltd, Pfizer Inc, Bayer AG, Abbott Laboratories, Janssen Pharmaceuticals, Sun Pharmaceutical Industries, Cipla Ltd DR, Gilead Sciences Inc, Biogen Inc, Organon & Co Ordinary Shares
Other key industry trends
In terms of revenue, South Africa accounted for 0.9% of the global gastrointestinal therapeutics market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Middle East & Africa, Saudi Arabia gastrointestinal therapeutics market is projected to lead the regional market in terms of revenue in 2033.
UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 186.3 million by 2033.
The burden of gastrointestinal diseases in the African region has been high owing to easy transmission of bacterial and viral contaminants. Rising investment by major market players and increasing R&D are factors anticipated to fuel growth.
Rising number of government initiatives intended to extensively increase awareness among locals is expected to bolster growth in the region. For instance, the standard treatment guidelines and essential medicines list released by the Health Republic of South Africa.
The South African Gastroenterological Society—Academy of Digestive Diseases (SAGES-ADD) is another such organization facilitating training and improving diagnosis among locals for various gastrointestinal diseases.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Gastrointestinal Therapeutics Market will help companies and investors design strategic landscapes.
Branded was the largest segment with a revenue share of 60.5% in 2025.
Horizon Databook has segmented the South Africa gastrointestinal therapeutics market based on branded, generics covering the revenue growth of each sub-segment from 2021 to 2033.
The burden of gastrointestinal diseases in the African region has been high owing to easy transmission of bacterial and viral contaminants. Rising investment by major market players and increasing R&D are factors anticipated to fuel growth.
Rising number of government initiatives intended to extensively increase awareness among locals is expected to bolster growth in the region. For instance, the standard treatment guidelines and essential medicines list released by the Health Republic of South Africa.
The South African Gastroenterological Society—Academy of Digestive Diseases (SAGES-ADD) is another such organization facilitating training and improving diagnosis among locals for various gastrointestinal diseases.
South Africa Gastrointestinal Therapeutics Market Drug Type Outlook (Revenue, USD Million , 2021-2033)
Branded
Generics
South Africa Gastrointestinal Therapeutics Market Drug Class Outlook (Revenue, USD Million , 2021-2033)
Aminosalicylates
Digestive Enzymes
Proton Pump Inhibitors
Laxatives
Anti-emetics
H2 Antagonists
Anti-diarrheals
Biologics/Biosimilar
Other Drug Classes
South Africa Gastrointestinal Therapeutics Market Route of Administration Outlook (Revenue, USD Million , 2021-2033)
Oral
Injectables
Others Route of Administrations
South Africa Gastrointestinal Therapeutics Market Application Outlook (Revenue, USD Million , 2021-2033)
Crohn's disease
Ulcerative colitis
GERD
IBS
Others Applications
South Africa Gastrointestinal Therapeutics Market Distribution Channel Outlook (Revenue, USD Million , 2021-2033)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Reasons to subscribe to gastrointestinal therapeutics market databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of gastrointestinal therapeutics market databook
Our clientele includes a mix of gastrointestinal therapeutics market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa gastrointestinal therapeutics market, including forecasts for subscribers. This country databook contains high-level insights into South Africa gastrointestinal therapeutics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
South Africa Gastrointestinal Therapeutics Market, 2021-2033 (US$M)